I. Ferrarini

Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients.

O. Goletti, M. Scalese, G. Bocci, 2017, Breast.

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

L. Antonuzzo, S. Pillozzi, F. Tomao, 2021, Gynecologic oncology reports.

Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study

P. Marchetti, G. Tonini, A. Fabi, 2014, Journal of Cancer.

Bilateral Anterior Uveitis Following Zoledronic Acid Therapy In BreastCancer: A Case Report

A. Falcone, A. Fontana, I. Bertolini, 2017 .

Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.

R. Danesi, O. Goletti, M. Scalese, 2014, Pharmacogenomics.

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

N. Tinari, S. Iacobelli, C. Ficorella, 2013, Journal of Cancer Research and Clinical Oncology.